AINewsnow

Moderna's personalized cancer vaccine cleared Phase 3 with a learned selector inside it

This story is from 2026-08-23. It is preserved in the archive; the latest stories are on the live feed.

Moderna announced on August 19, 2026 that its individualized cancer treatment intismeran autogene, given with Merck's pembrolizumab, produced positive topline Phase 3 results in patients whose stage two to four melanoma had been completely surgically removed. In Moderna's own words it is the "first…

Read the full story at DEV Community — Machine Learning ↗

Timeline · 1 report

  1. 2026-08-23 03:09 · DEV Community — Machine Learning
    Moderna's personalized cancer vaccine cleared Phase 3 with a learned selector inside it

More stories

  1. Anthropic says Claude 'leads' 26 percent of its AI R&D work — Engadget
  2. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  3. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  4. Optimizing agent system prompts with Amazon Bedrock AgentCore — AWS Machine Learning Blog
  5. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  6. Introducing Astra for Law — OpenAI News
  7. OpenAI reveals cases of ‘concerning’ AI behaviour as it announces new disclosure system — The Guardian AI
  8. What It Takes to Bring Up a Multi-Rack NVIDIA Vera Rubin NVL72 Cluster — CoreWeave Blog

Get the daily brief of stories like this at 6:30 every morning →